Genetic PCSK9 inhibition via base editing appeared safe and demonstrated dose-dependent, durable reductions in PCSK9 and LDL cholesterol, researchers reported.At the highest dose, VERVE-102 (Verve ...
LDL-C Reductions Up to 55% and Blood PCSK9 Protein Reductions Up to 84% Observed After a Single Infusion of VERVE-101 at Potentially Therapeutic Doses Patients included in both the safety and efficacy ...
A phase 1 NEJM interim analysis found that a single infusion of the investigational base-editing therapy VERVE-102 produced ...
MedPage Today on MSN
So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia
Tweaked lipid nanoparticle delivery system showed early safety ...
Since the late 1980s, statins have been the mainstay of cholesterol management, lowering low-density lipoprotein (LDL) levels and preventing countless heart attacks. Yet many patients do not achieve ...
Eleven medical organizations advised changes to preventive cardiac care that it says could markedly reduce heart attacks and strokes. By Gina Kolata People at risk of heart disease should start trying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results